BackHemab Therapeutics Holdings Common Stock Overview

Hemab Therapeutics Holdings Common Stock Operating Income

Hemab Therapeutics Holdings Common Stock operating income — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-23612000.00

As of Mar 31, 2026

Annual Operating Income (TTM)

N/A

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Hemab Therapeutics Holdings Common Stock (COAG) FAQ

Stockcircle tracks operating income for Hemab Therapeutics Holdings Common Stock (COAG), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Operating Income page is built for Hemab Therapeutics Holdings Common Stock's historical operating income trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use operating income as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main COAG overview so you can move from this figure to the surrounding analysis quickly.